Antimicrobial Optimization in the ICU: Treating HABP/VABP in the Critically Ill Patient
Back to course
Video Transcription
Video Summary
Asset Subtitle
Pulmonary, Infection, Pharmacology, 2022
Asset Caption
The goal of this activity is to improve the knowledge and competence of health care providers about the diagnosis, treatment, and management of HABP/VABP in critically ill patients. Learning Objectives: -Describe the role of rapid diagnostics in HABP/VABP caused by MDR gram-negative infections -Appropriately use new antimicrobial agents for both empiric and targeted therapy in MDR gram-negative HABP/VABP -Identify strategies for managing critically ill patients with unique clinical scenarios, such as augmented or diminished renal clearance -Implement effective approaches to antimicrobial stewardship and minimizing TTET This program is supported by educational grants from AbbVie and Merck Sharp & Dohme Corp
Meta Tag
Content Type Presentation
Knowledge Area Pulmonary
Knowledge Area Infection
Knowledge Area Pharmacology
Knowledge Level Advanced
Membership Level Select
Tag Ventilator Associated Pneumonia VAP
Tag Nosocomial Infection
Tag Antibiotics
Year 2022
Keywords
bacterial pneumonia
critically ill patients
antimicrobial agents
hospital-acquired pneumonia
multidrug-resistant pseudomonas infection
ventilator-associated pneumonia
rapid diagnostic tests
continuous renal replacement therapy
extracorporeal membrane oxygenation